Science & Health Apr 14, 2020
Coronavirus drug hopefuls are cheap to make but may quickly be in short supply
by John Miller
Drugs being repurposed in hopes they will help against COVID-19 cost relatively little to make but may prove challenging to produce in quantities needed for a pandemic, a drug pricing expert has said. "Any pharmaceutical company manufacturing any treatment currently in clinical trials against coronavirus ...
